Peptide Therapeutics Market 2026 expected to reach $83.57 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Peptide Therapeutics Market Over The 2026–2030 Period?

The peptide therapeutics market size has seen significant expansion in recent years. It is forecast to rise from $49.21 billion in 2025 to $54.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.0%. The expansion observed historically is attributed to the initial acceptance of peptide drugs, advancements in peptide synthesis techniques, a growing prevalence of chronic and rare diseases, progress in pharmacology and biochemistry, and the emergence of contract research organizations.

The peptide therapeutics market size is projected to experience substantial expansion in the coming years. Its valuation is set to reach $83.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.2%. This anticipated growth during the forecast timeframe stems from several factors, including the emergence of personalized medicine, augmented investment in peptide-based therapies, the incorporation of AI into drug discovery processes, the broadening of biologics manufacturing capabilities, and the expansion of healthcare solution markets in developing regions. Key trends anticipated over the same period encompass the development of targeted peptide drugs, advancements in peptide drug delivery, the creation of multi-functional peptide therapeutics, innovative methods for natural peptide extraction and synthesis, and the utilization of combination therapies involving peptides.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

What Underlying Factors Are Accelerating The Growth Of The Peptide Therapeutics Market?

The increasing occurrence of chronic diseases is anticipated to propel the expansion of the peptide therapeutics market. Chronic diseases are persistent health conditions that often cannot be completely healed, though they can occasionally be managed and controlled. The rise in chronic diseases is attributed to factors like increased consumption of tobacco products, poor nutrition, lack of physical activity, excessive alcohol use, and more. Peptide therapeutics play a role in both the prevention and treatment of specific chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the population in the US aged 50 and older afflicted with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million, by 2050. Consequently, the escalating prevalence of chronic diseases is expected to drive the peptide therapeutics market during the forecast period.

How Is The Peptide Therapeutics Market Segmented Across Key Categories?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

Which Upcoming Trends Are Expected To Influence The Peptide Therapeutics Market?

Leading companies operating within the peptide therapeutics market are concentrating on introducing advanced solutions, such as the cell culture process, to secure a competitive advantage. The cell culture process entails cultivating cells outside their natural surroundings under controlled conditions, which includes isolating target cells from living tissue and subsequently maintaining them. For instance, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, unveiled cQrex KC. cQrex KC is a next-generation peptide for biopharma applications, specifically engineered for the cell culture process employed in manufacturing biological drugs. It allows cell culture process developers to optimize cystine supply and enhance cell culture productivity. cQrex KC further supports the development of vaccines, viral vectors, and cell therapies.

Who Are The Dominant Players Shaping The Peptide Therapeutics Market Landscape?

Major companies operating in the peptide therapeutics market are Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

Read the full peptide therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Which Region Is Projected To Dominate The Peptide Therapeutics Market During The Forecast Period?

North America was the largest region in the peptide therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Peptide Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp

Browse Through More Reports Similar to the Global Peptide Therapeutics Market 2026, By The Business Research Company

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Peptide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Peptide Based Metabolic Disorders Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795